{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Selexipag  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Selexipag. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Selexipag  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "selexipag",
    "trial_2_text": "Selexipag  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Selexipag Supplement: 60 participants will take Selexipag 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Selexipag. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Selexipag  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.17279215157032013,
      "173": 0.15924333035945892,
      "123": 0.15889722108840942,
      "78": 0.1541471779346466,
      "46": 0.15108050405979156,
      "21": 0.1334826499223709,
      "17": 0.12342017889022827,
      "14": 0.12251995503902435,
      "20": 0.11988753080368042,
      "9": 0.1197441965341568,
      "49": 0.11867307871580124,
      "177": 0.10794765502214432,
      "68": 0.1050238087773323,
      "67": 0.10378333181142807,
      "37": 0.09994761645793915,
      "126": 0.08624140918254852,
      "114": 0.08396659046411514,
      "396": 0.08284159004688263,
      "64": 0.08112388104200363,
      "188": 0.08088283240795135,
      "116": 0.08065501600503922,
      "200": 0.07982256263494492,
      "104": 0.07957090437412262,
      "189": 0.07822450995445251,
      "18": 0.07742995023727417,
      "79": 0.07588541507720947,
      "76": 0.07557445764541626,
      "2": 0.0742945745587349,
      "61": 0.07287219166755676,
      "77": 0.07249947637319565,
      "85": 0.07141779363155365,
      "228": 0.06964140385389328,
      "151": 0.06859620660543442,
      "30": 0.06664159893989563,
      "139": 0.06543386727571487,
      "180": 0.0639781653881073,
      "131": 0.06303886324167252,
      "276": 0.06219840422272682,
      "350": 0.061668649315834045,
      "72": 0.06039367616176605,
      "147": 0.057742681354284286,
      "28": 0.05606437101960182,
      "101": 0.05576452240347862,
      "29": 0.05421113595366478,
      "204": 0.053855668753385544,
      "69": 0.053846802562475204,
      "5": 0.05338562652468681,
      "96": 0.05214480310678482,
      "269": 0.0519518107175827,
      "239": 0.051653314381837845,
      "441": 0.05147416144609451,
      "122": 0.047393787652254105,
      "138": 0.046336185187101364,
      "4": 0.046111926436424255,
      "38": 0.04574410244822502,
      "11": 0.04549216106534004,
      "243": 0.044493719935417175,
      "268": 0.04398854076862335,
      "27": 0.0438656210899353,
      "86": 0.043289389461278915,
      "142": 0.04096895456314087,
      "253": 0.04037724435329437,
      "356": 0.04014721140265465,
      "75": 0.03923722729086876,
      "286": 0.03913351520895958,
      "454": 0.03807295858860016,
      "36": 0.038015253841876984,
      "193": 0.037414681166410446,
      "456": 0.03693192079663277,
      "82": 0.036927562206983566,
      "466": 0.0366513766348362,
      "97": 0.03627154231071472,
      "394": 0.036246199160814285,
      "339": 0.035707902163267136,
      "221": 0.03567303717136383,
      "164": 0.03547462448477745,
      "191": 0.03542134165763855,
      "25": 0.033783163875341415,
      "179": 0.03353254497051239,
      "208": 0.033525560051202774,
      "163": 0.033128444105386734,
      "261": 0.032976213842630386,
      "186": 0.03262517601251602,
      "121": 0.03243440389633179,
      "747": 0.03224004805088043,
      "92": 0.032075557857751846,
      "282": 0.03197987750172615,
      "211": 0.03185092285275459,
      "118": 0.0317620187997818,
      "271": 0.03142685815691948,
      "508": 0.03131609782576561,
      "22": 0.03105599246919155,
      "361": 0.030869796872138977,
      "102": 0.03085680678486824,
      "382": 0.030786613002419472,
      "257": 0.03045428916811943,
      "33": 0.02970067784190178,
      "205": 0.029620463028550148,
      "130": 0.029367730021476746,
      "35": 0.029104502871632576
    },
    "trial_2_ae": {
      "87": 0.17279215157032013,
      "173": 0.15924333035945892,
      "123": 0.15889722108840942,
      "78": 0.1541471779346466,
      "46": 0.15108050405979156,
      "21": 0.1334826499223709,
      "17": 0.12342017889022827,
      "14": 0.12251995503902435,
      "20": 0.11988753080368042,
      "9": 0.1197441965341568,
      "49": 0.11867307871580124,
      "177": 0.10794765502214432,
      "68": 0.1050238087773323,
      "67": 0.10378333181142807,
      "37": 0.09994761645793915,
      "126": 0.08624140918254852,
      "114": 0.08396659046411514,
      "396": 0.08284159004688263,
      "64": 0.08112388104200363,
      "188": 0.08088283240795135,
      "116": 0.08065501600503922,
      "200": 0.07982256263494492,
      "104": 0.07957090437412262,
      "189": 0.07822450995445251,
      "18": 0.07742995023727417,
      "79": 0.07588541507720947,
      "76": 0.07557445764541626,
      "2": 0.0742945745587349,
      "61": 0.07287219166755676,
      "77": 0.07249947637319565,
      "85": 0.07141779363155365,
      "228": 0.06964140385389328,
      "151": 0.06859620660543442,
      "30": 0.06664159893989563,
      "139": 0.06543386727571487,
      "180": 0.0639781653881073,
      "131": 0.06303886324167252,
      "276": 0.06219840422272682,
      "350": 0.061668649315834045,
      "72": 0.06039367616176605,
      "147": 0.057742681354284286,
      "28": 0.05606437101960182,
      "101": 0.05576452240347862,
      "29": 0.05421113595366478,
      "204": 0.053855668753385544,
      "69": 0.053846802562475204,
      "5": 0.05338562652468681,
      "96": 0.05214480310678482,
      "269": 0.0519518107175827,
      "239": 0.051653314381837845,
      "441": 0.05147416144609451,
      "122": 0.047393787652254105,
      "138": 0.046336185187101364,
      "4": 0.046111926436424255,
      "38": 0.04574410244822502,
      "11": 0.04549216106534004,
      "243": 0.044493719935417175,
      "268": 0.04398854076862335,
      "27": 0.0438656210899353,
      "86": 0.043289389461278915,
      "142": 0.04096895456314087,
      "253": 0.04037724435329437,
      "356": 0.04014721140265465,
      "75": 0.03923722729086876,
      "286": 0.03913351520895958,
      "454": 0.03807295858860016,
      "36": 0.038015253841876984,
      "193": 0.037414681166410446,
      "456": 0.03693192079663277,
      "82": 0.036927562206983566,
      "466": 0.0366513766348362,
      "97": 0.03627154231071472,
      "394": 0.036246199160814285,
      "339": 0.035707902163267136,
      "221": 0.03567303717136383,
      "164": 0.03547462448477745,
      "191": 0.03542134165763855,
      "25": 0.033783163875341415,
      "179": 0.03353254497051239,
      "208": 0.033525560051202774,
      "163": 0.033128444105386734,
      "261": 0.032976213842630386,
      "186": 0.03262517601251602,
      "121": 0.03243440389633179,
      "747": 0.03224004805088043,
      "92": 0.032075557857751846,
      "282": 0.03197987750172615,
      "211": 0.03185092285275459,
      "118": 0.0317620187997818,
      "271": 0.03142685815691948,
      "508": 0.03131609782576561,
      "22": 0.03105599246919155,
      "361": 0.030869796872138977,
      "102": 0.03085680678486824,
      "382": 0.030786613002419472,
      "257": 0.03045428916811943,
      "33": 0.02970067784190178,
      "205": 0.029620463028550148,
      "130": 0.029367730021476746,
      "35": 0.029104502871632576
    }
  },
  "safety": {
    "trial_1_safety": 0.18583762645721436,
    "trial_2_safety": 0.18583762645721436
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4734453558921814
  }
}